Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC
UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1920p (from 1900p).
Broker Forecasts data provided by...
Thu, 14/05/2020 - 10:10